Insights

Clinical Impact Strong case for expansion with hospitals and GI clinics by emphasizing cost reductions and improved patient management demonstrated by PathFinderTG and supported by Medicare/private payer coverage.

payer Coverage Leverage favorable payer decisions and published economic studies to approach managed care organizations and value-based contracting opportunities that reward cost-effective molecular diagnostics.

Market Position Target mid-sized diagnostic networks and specialty labs seeking advanced molecular profiling capabilities to complement existing pathology workflows and differentiate from larger competitors.

Strategic Partnerships Propose collaboration with gastroenterology groups, academic centers, and CROs for broader validation studies, joint publications, and clinical evidence generation to accelerate adoption.

Growth Readiness Highlight scalable CLIA/CAP-certified operations and R&D integration to support multi-center deployments, repertoire expansion, and faster onboarding of new payers and clinical indications.

Similar companies to RedPath Integrated Pathology

RedPath Integrated Pathology's Email Address Formats

RedPath Integrated Pathology uses at least 4 email formats:
RedPath Integrated Pathology Email FormatsExamplePercentage
FLast@redpathip.comJDoe@redpathip.com
66%
First.Last@redpathip.comJohn.Doe@redpathip.com
13%
Last@redpathip.comDoe@redpathip.com
14%
FL@redpathip.comJD@redpathip.com
7%

Frequently Asked Questions

What is RedPath Integrated Pathology's phone number?

Minus sign iconPlus sign icon
You can contact RedPath Integrated Pathology's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is RedPath Integrated Pathology's official website and social media links?

Minus sign iconPlus sign icon
RedPath Integrated Pathology's official website is redpathip.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does RedPath Integrated Pathology generate?

Minus sign iconPlus sign icon
As of September 2026, RedPath Integrated Pathology's annual revenue is estimated to be $10M - $25M.

What is RedPath Integrated Pathology's SIC code and NAICS code?

Minus sign iconPlus sign icon
RedPath Integrated Pathology's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does RedPath Integrated Pathology have currently?

Minus sign iconPlus sign icon
As of September 2026, RedPath Integrated Pathology has approximately 20 employees across 2 continents, including North America and South America. Key team members include Chief Accounting Officer: T. F., Vice President Clinical Operations: E. L. and Director Business Development: D. H. Explore RedPath Integrated Pathology's employee directory with LeadIQ.

What industry does RedPath Integrated Pathology belong to?

Minus sign iconPlus sign icon
RedPath Integrated Pathology operates in the Biotechnology Research industry.

What is RedPath Integrated Pathology's email format?

Minus sign iconPlus sign icon
RedPath Integrated Pathology's email format typically follows the pattern of FLast@redpathip.com. Find more RedPath Integrated Pathology email formats with LeadIQ.

How much funding has RedPath Integrated Pathology raised to date?

Minus sign iconPlus sign icon
As of September 2026, RedPath Integrated Pathology has raised $9.4M in funding. The last funding round occurred on Apr 09, 2013 for $613K.
RedPath Integrated Pathology logo

RedPath Integrated Pathology

Biotechnology ResearchUnited States11-50 Employees

RedPath Integrated Pathology is a Pittsburgh-based molecular diagnostics laboratory focused on providing novel solutions for clinicians. Its PathFinderTG platform generates mutational profiles to assist physicians in resolving complex diagnostic questions for patients at risk of cancer, with all clinical testing and research and development conducted in its CLIA-certified and CAP-accredited facility. The company supports gastroenterologists, pathologists, and other physicians by offering molecular diagnostic services aimed at improving clinical management of patients. Located in the United States and operating in the biotechnology research industry, RedPath leverages a long history of scientific and clinical work, with its platform underpinning studies published in major medical journals and supported by healthcare economic analyses. A recent development noted is the company’s continued evidence base and favorable coverage decisions from Medicare and private payers, reflecting its integration into the broader healthcare landscape.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
11-50

Section iconFunding & Financials

  • $9.4M

    RedPath Integrated Pathology has raised a total of $9.4M of funding over 5 rounds. Their latest funding round was raised on Apr 09, 2013 in the amount of $613K as a Debt Financing.

  • $10M - $25M

    RedPath Integrated Pathology's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.